KR20020060213A - 허혈성 상태의 치료 또는 예방용 의약 제조를 위한2-이미다졸릴 치환된 카비놀의 용도 - Google Patents

허혈성 상태의 치료 또는 예방용 의약 제조를 위한2-이미다졸릴 치환된 카비놀의 용도 Download PDF

Info

Publication number
KR20020060213A
KR20020060213A KR1020027005275A KR20027005275A KR20020060213A KR 20020060213 A KR20020060213 A KR 20020060213A KR 1020027005275 A KR1020027005275 A KR 1020027005275A KR 20027005275 A KR20027005275 A KR 20027005275A KR 20020060213 A KR20020060213 A KR 20020060213A
Authority
KR
South Korea
Prior art keywords
formula
medicament
treatment
compound
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020027005275A
Other languages
English (en)
Korean (ko)
Inventor
바이헤르트안드레아스
알부스우도
얀센한스-빌리
Original Assignee
로버트 흐라이탁, 미쉘 베스트
아벤티스 파마 도이칠란트 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로버트 흐라이탁, 미쉘 베스트, 아벤티스 파마 도이칠란트 게엠베하 filed Critical 로버트 흐라이탁, 미쉘 베스트
Publication of KR20020060213A publication Critical patent/KR20020060213A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020027005275A 1999-10-27 2000-10-14 허혈성 상태의 치료 또는 예방용 의약 제조를 위한2-이미다졸릴 치환된 카비놀의 용도 Withdrawn KR20020060213A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19951701.0 1999-10-27
DE19951701A DE19951701A1 (de) 1999-10-27 1999-10-27 Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
PCT/EP2000/010126 WO2001030327A2 (de) 1999-10-27 2000-10-14 Verwendung von 2-imidazolyl-substituierten carbinolen zur herstellung eines medikaments zur behandlung oder prophylaxe von durch ischämischen zuständen

Publications (1)

Publication Number Publication Date
KR20020060213A true KR20020060213A (ko) 2002-07-16

Family

ID=7927020

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027005275A Withdrawn KR20020060213A (ko) 1999-10-27 2000-10-14 허혈성 상태의 치료 또는 예방용 의약 제조를 위한2-이미다졸릴 치환된 카비놀의 용도

Country Status (30)

Country Link
US (1) US6291502B1 (cg-RX-API-DMAC7.html)
EP (1) EP1227811B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003512419A (cg-RX-API-DMAC7.html)
KR (1) KR20020060213A (cg-RX-API-DMAC7.html)
CN (1) CN1188125C (cg-RX-API-DMAC7.html)
AR (1) AR026241A1 (cg-RX-API-DMAC7.html)
AT (1) ATE257702T1 (cg-RX-API-DMAC7.html)
AU (1) AU778836B2 (cg-RX-API-DMAC7.html)
BR (1) BR0015024A (cg-RX-API-DMAC7.html)
CA (1) CA2388956A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ295925B6 (cg-RX-API-DMAC7.html)
DE (2) DE19951701A1 (cg-RX-API-DMAC7.html)
DK (1) DK1227811T3 (cg-RX-API-DMAC7.html)
EE (1) EE200200218A (cg-RX-API-DMAC7.html)
ES (1) ES2213621T3 (cg-RX-API-DMAC7.html)
HK (1) HK1048938B (cg-RX-API-DMAC7.html)
HR (1) HRP20020362A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0203213A3 (cg-RX-API-DMAC7.html)
IL (1) IL149208A0 (cg-RX-API-DMAC7.html)
NO (1) NO20021909L (cg-RX-API-DMAC7.html)
NZ (1) NZ518586A (cg-RX-API-DMAC7.html)
PL (1) PL355911A1 (cg-RX-API-DMAC7.html)
PT (1) PT1227811E (cg-RX-API-DMAC7.html)
RU (1) RU2257205C2 (cg-RX-API-DMAC7.html)
SK (1) SK5512002A3 (cg-RX-API-DMAC7.html)
TR (1) TR200201140T2 (cg-RX-API-DMAC7.html)
TW (1) TWI246424B (cg-RX-API-DMAC7.html)
WO (1) WO2001030327A2 (cg-RX-API-DMAC7.html)
YU (1) YU20902A (cg-RX-API-DMAC7.html)
ZA (1) ZA200203035B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726829B2 (en) * 1997-04-08 2004-04-27 Scimed Life Systems, Inc. Method of manufacturing a stent
EP1465863B1 (en) * 2002-01-04 2008-07-09 NeuroSearch A/S Potassium channel modulators
AR049847A1 (es) * 2004-07-29 2006-09-06 Merck & Co Inc Inhibidores de los canales de potasio
RU2373934C1 (ru) * 2008-03-19 2009-11-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
WO2015175845A1 (en) * 2014-05-15 2015-11-19 Peloton Therapeutics, Inc. Benzimidazole derivatives and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
BE794940A (fr) * 1972-02-04 1973-08-02 Gist Brocades Nv Nouveaux composes anorexigenes
US4152441A (en) 1972-02-04 1979-05-01 Gist-Brocades N.V. Analgesic imidazolemethanols
US5063220A (en) * 1988-10-21 1991-11-05 Syntex Pharmaceuticals, Ltd. Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US6175013B1 (en) * 1994-06-10 2001-01-16 Eli Lilly And Company Imidazolinyl tachykinin receptor antagonists
JP3404749B2 (ja) 1996-06-27 2003-05-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ N―[4―(ヘテロアリールメチル)フェニル]―ヘテロアリールアミン

Also Published As

Publication number Publication date
SK5512002A3 (en) 2002-08-06
DK1227811T3 (da) 2004-04-19
HUP0203213A2 (en) 2003-05-28
WO2001030327A3 (de) 2002-03-14
EE200200218A (et) 2003-06-16
HRP20020362A2 (en) 2004-02-29
CA2388956A1 (en) 2001-05-03
NO20021909D0 (no) 2002-04-23
HUP0203213A3 (en) 2003-07-28
CZ295925B6 (cs) 2005-11-16
RU2002113666A (ru) 2004-01-10
DE19951701A1 (de) 2001-05-03
IL149208A0 (en) 2002-11-10
HK1048938A1 (en) 2003-04-25
ZA200203035B (en) 2003-03-14
RU2257205C2 (ru) 2005-07-27
WO2001030327A2 (de) 2001-05-03
CN1188125C (zh) 2005-02-09
US6291502B1 (en) 2001-09-18
PL355911A1 (en) 2004-05-31
PT1227811E (pt) 2004-05-31
TR200201140T2 (tr) 2002-11-21
BR0015024A (pt) 2002-06-18
CZ20021452A3 (cs) 2002-07-17
TWI246424B (en) 2006-01-01
EP1227811B1 (de) 2004-01-14
AU778836B2 (en) 2004-12-23
ATE257702T1 (de) 2004-01-15
NO20021909L (no) 2002-04-23
DE50005040D1 (de) 2004-02-19
YU20902A (sh) 2004-11-25
AR026241A1 (es) 2003-02-05
AU1138201A (en) 2001-05-08
JP2003512419A (ja) 2003-04-02
EP1227811A2 (de) 2002-08-07
ES2213621T3 (es) 2004-09-01
NZ518586A (en) 2004-07-30
CN1373663A (zh) 2002-10-09
HK1048938B (zh) 2005-06-10

Similar Documents

Publication Publication Date Title
KR100360127B1 (ko) 치환된1-옥소-1,2-디하이드로이소퀴놀리노일구아니딘,1,1-디옥소-2h-1,2-벤조티아지노일구아니딘및이들을함유하는약제
US6043260A (en) Method of treating heart failure
DK159770B (da) Analogifremgangsmaade til fremstilling af etherforbindelser eller farmakologisk acceptable salte deraf, samt ether-mellemprodukter til anvendelse som udgangsforbindelser ved fremgangsmaaden
US4336397A (en) 2,4-Dioxo-4-substituted-1-butanoic acid derivatives useful in treating urinary tract calcium oxalate lithiasis
KR100368513B1 (ko) 퍼플루오로알킬그룹을갖는페닐-치환된알케닐카보구아니디드,이의제조방법및이를함유하는약제학적조성물
SK281766B6 (sk) Substituované sulfónimidamidy, spôsob ich prípravy, ich použitie ako liečiva alebo diagnostika, ako i liečivo, ktoré ich obsahuje
JPH06271540A (ja) カルシウム取込みの抑制剤
US6291502B1 (en) Use of 2-imidazolyl-substituted carbinols for the production of a medicament for the treatment or phophylaxis of diseases caused by ischemic conditions
US9856232B1 (en) Dihydropyrimidinone derivatives
CN1463972A (zh) 新的n-取代吡啶基苯并异硒唑酮化合物及其制法和其药物组合物与用途
KR20020041831A (ko) 허혈성 상태로부터 유발되는 질병의 치료 또는 예방용의약 제조를 위한 2-아미노-3,4-디하이드로-퀴나졸린의 용도
CN104983731B (zh) (z)‑2‑亚氨基‑5‑(3,5‑二甲氧基苯甲撑基)‑1‑甲基咪唑烷‑4‑酮在制备心血管药物中的应用
KR20040068322A (ko) 치환된 이미다졸리딘, 이의 제조 방법, 약제로서 또는진단용 이의 용도, 및 치환된 이미다졸리딘을 함유하는 약제
JP3805905B2 (ja) 芳香族抗真菌剤
HK1050480B (en) Use of 2-amino-3, 4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions
JPH09328462A (ja) オルト−置換されたベンゾイルグアニジン、それらの製造方法、医薬または診断薬としてのそれらの使用およびそれらを含有する医薬

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20020425

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid